THE EFFECT OF CLOPENTHIXOL ON CHRONIC PSYCHIATRIC PATIENTS
Abstract
In our clinical trial with 20 male chronic patients on a mental hospital ward, clopenthixol appeared to have observable antipsychotic properties with relatively little toxicity. The observation that this drug was therapeutically effective in certain chronic sohizaphrenic patients where previous treatments had failed is in accordance with the findings of other clinical investigators and suggests that clopenthixol may deserve a place among the clinically used antipsychotic compounds.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
